GATEWAY INVESTMENT ADVISERS LLC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1114618
CINCINNATI, OH
Position in JAZZ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$993,519
+$714,860 QoQ
Shares Held
4,123
+179.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#329
of 643 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $83,759,285 across 16 Biotechnology names. JAZZ ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $38,916,300 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,289 | $33,424,464 | |
| 3 | INCY |
Incyte Corp
|
23,398 | $2,652,397 | |
| 4 | EXEL |
Exelixis, Inc.
|
43,083 | $2,344,146 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
22,728 | $1,300,496 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
4,123 | $993,519 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,900 | $872,987 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,111 | $634,847 |
All Filings in JAZZ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $993,519 | 4,123 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $278,659 | 1,474 | Shares | Sole | 2026-04-13 | |
| 2024-09-30 | $223,599 | 2,007 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $227,334 | 2,130 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $258,662 | 2,148 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $269,370 | 2,190 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,942,376 | 15,006 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,862,401 | 15,023 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,199,193 | 15,029 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,433,778 | 15,277 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,014,011 | 15,110 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,383,364 | 15,277 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $2,378,170 | 15,277 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,938,136 | 15,213 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $256,904 | 1,973 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $349,595 | 1,968 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $323,480 | 1,968 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $316,730 | 1,919 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $276,196 | 1,937 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,488,167 | 22,550 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $2,635,031 | 26,419 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||